Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1985 May;38(5):588–592. doi: 10.1136/jcp.38.5.588

Relation between raised concentrations of fucose, sialic acid, and acute phase proteins in serum from patients with cancer: choosing suitable serum glycoprotein markers.

G A Turner, A W Skillen, P Buamah, D Guthrie, J Welsh, J Harrison, A Kowalski
PMCID: PMC499217  PMID: 2582003

Abstract

Serum concentrations of fucose, sialic acid, and eight acute phase proteins were measured in single specimens from patients with cancer in order to determine whether the raised concentrations of protein bound sugars commonly found in cancer correlate with increased concentrations of the acute phase proteins. Strong positive correlations were found only with alpha 1-acid glycoprotein, alpha 1-antitrypsin, and haptoglobins. Changes in protein bound sugars and acute phase proteins were also examined in relation to patients' disease states. Serum fucose was raised more often in patients with advanced disease than in those in whom the spread of the tumour was more restricted; increased sialic acid concentrations, however, were found with a similar frequency in both these groups. Combined use of fucose and sialic acid values gave a high degree of marker positivity which could be only slightly improved on by including measurement of acute phase proteins. The combined use of serum fucose and sialic acid concentrations may have value in monitoring patients with cancer: the sialic acid provides an index of the acute phase response and the fucose a measure of the tumour spread.

Full text

PDF
589

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer C. H., Vischer P., Grünholz H., Reutter W. Glycosyltransferases and glycosidases in Morris hepatomas. Cancer Res. 1977 May;37(5):1513–1518. [PubMed] [Google Scholar]
  2. Bauer C., Köttgen E., Reutter W. Elevated activities of alpha-2-and alpha-3-fucosyltransferases in human serum as a new indicator of malignancy. Biochem Biophys Res Commun. 1976 May 23;76(2):488–494. doi: 10.1016/0006-291x(77)90751-3. [DOI] [PubMed] [Google Scholar]
  3. Bradley W. P., Blasco A. P., Weiss J. F., Alexander J. C., Jr, Silverman N. A., Chretien P. B. Correlations among serum protein-bound carbohydrates, serum glycoproteins, lymphocyte reactivity, and tumors burden in cancer patients. Cancer. 1977 Nov;40(5):2264–2272. doi: 10.1002/1097-0142(197711)40:5<2264::aid-cncr2820400537>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  4. Chatterjee S. K., Kim U. Fucosyltransferase activity in metastasizing and nonmetastasizing rat mammary carcinomas. J Natl Cancer Inst. 1978 Jul;61(1):151–162. doi: 10.1093/jnci/61.1.151. [DOI] [PubMed] [Google Scholar]
  5. Cooper E. H., Stone J. Acute phase reactant proteins in cancer. Adv Cancer Res. 1979;30:1–44. doi: 10.1016/s0065-230x(08)60893-3. [DOI] [PubMed] [Google Scholar]
  6. Doetschman T. C. Cell surface turnover and shedding of fucosyl-glycoprotein in L6 cells. Cell Biol Int Rep. 1980 Apr;4(4):379–390. doi: 10.1016/0309-1651(80)90219-2. [DOI] [PubMed] [Google Scholar]
  7. Hogan-Ryan A., Fennelly J. J., Jones M., Cantwell B., Duffy M. J. Serum sialic acid and CEA concentrations in human breast cancer. Br J Cancer. 1980 Apr;41(4):587–592. doi: 10.1038/bjc.1980.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kim Y. S., Kim Y. W., Siddiqui B., Tsao D. Membrane-associated, fucose-containing glycoproteins and glycolipids of cultured epithelial cells from human colonic adenocarcinoma and fetal intestine. Eur J Cancer Clin Oncol. 1982 Dec;18(12):1329–1336. doi: 10.1016/0277-5379(82)90137-7. [DOI] [PubMed] [Google Scholar]
  9. Miyauchi T., Yonezawa S., Takamura T., Chiba T., Tejima S., Ozawa M., Sato E., Muramatsu T. A new fucosyl antigen expressed on colon adenocarcinoma and embryonal carcinoma cells. Nature. 1982 Sep 9;299(5879):168–169. doi: 10.1038/299168a0. [DOI] [PubMed] [Google Scholar]
  10. Silver H. K., Karim K. A., Salinas F. A. Relationship of total serum sialic acid to sialylglycoprotein acute-phase reactants in malignant melanoma. Br J Cancer. 1980 May;41(5):745–750. doi: 10.1038/bjc.1980.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Skoza L., Mohos S. Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical de-O-acetylation. Biochem J. 1976 Dec 1;159(3):457–462. doi: 10.1042/bj1590457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tatsumura T., Sato H., Mori A., Komori Y., Yamamoto K., Fukatani G., Kuno S. Clinical significance of fucose level in glycoprotein fraction of serum in patients with malignant tumors. Cancer Res. 1977 Nov;37(11):4101–4103. [PubMed] [Google Scholar]
  13. Tsay G. C., Dawson G. A sensitive spectrophotometric method for detection of L-fucose. Anal Biochem. 1977 Apr;78(2):423–427. doi: 10.1016/0003-2697(77)90103-8. [DOI] [PubMed] [Google Scholar]
  14. Vischer P., Reutter W. Specific alterations of fucoprotein biosynthesis in the plasma membrane of Morris hepatoma 7777. Eur J Biochem. 1978 Mar 15;84(2):363–368. doi: 10.1111/j.1432-1033.1978.tb12176.x. [DOI] [PubMed] [Google Scholar]
  15. Waalkes T. P., Mrochek J. E., Dinsmore S. R., Tormey D. C. Serum protein-bound carbohydrates for following the course of disease in patients with metastatic breast carcinoma. J Natl Cancer Inst. 1978 Sep;61(3):703–707. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES